# clm_B5FD1F0507D0

subject: Vertex Pharmaceuticals (/record/vertex-pharmaceuticals.md)  
predicate: quarterly_research_and_development  
value: 173,604,000 United States dollar  
valid_from: 2011-06-30  
valid_to: 2011-09-30  
published: 2011-08-09  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_B00D340EC942  
last_updated: 2026-11-08  
cite: AsOf. "Vertex Pharmaceuticals quarterly research and development: 173,604,000 United States dollar", as of 2011-06-30 (until 2011-09-30). Claim clm_B5FD1F0507D0, https://asof.is/claim/clm_B5FD1F0507D0, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/875320/000104746911007153/0001047469-11-007153-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2011, filed 2011-08-09  

## Sources

- https://www.sec.gov/Archives/edgar/data/875320/000104746911007153/0001047469-11-007153-index.htm (primary, SEC EDGAR 10-Q Q2 FY2011, published 2011-08-09)

## Supersedes

- [Vertex Pharmaceuticals](/record/vertex-pharmaceuticals.md) | quarterly_research_and_development | 158,612,000 United States dollar | valid 2011-03-31 to 2011-06-30 | conf 0.95 | superseded | superseded_by [clm_B5FD1F0507D0](/claim/clm_B5FD1F0507D0.md) | [clm_35956A6601A7](/claim/clm_35956A6601A7.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.